Susan Quaggin
Director/Board Member at ABBVIE INC.
Net worth: 221 157 $ as of 2024-04-29
Profile
Susan E.
Quaggin currently works at AbbVie, Inc., as Independent Director from 2023, American Society of Nephrology, as Director, and Mannin Research, Inc., as Director & Chief Scientific Officer.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ABBVIE, INC.
0.00% | 2024-05-02 | 1,322 ( 0.00% ) | 221 157 $ | 2024-04-29 |
Susan Quaggin active positions
| Companies | Position | Start |
|---|---|---|
| ABBVIE INC. | Director/Board Member | 2023-10-10 |
Mannin Research, Inc.
 Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
American Society of Nephrology
 American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Private companies | 2 |
|---|---|
Mannin Research, Inc.
Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada. | Health Technology |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Health Services |
- Stock Market
- Insiders
- Susan Quaggin
